CoRE and the Asian Development Bank (ADB) have teamed up to strengthen the regulatory systems in the Asia-Pacific region, specifically the low-resourced developing member countries (DMCs).
The overarching goal of this collaboration is to enable access to safe, efficacious and quality health products, through a range of scientific and regulatory activities. This is deployed across the entire product life cycle, including manufacturing and surveillance of therapeutic products for malaria and other communicable disease threats.
Through this collaboration, CoRE aims to build on the work bythe World Health Organization (WHO) and other partners to strengthen the capacity and capabilities of regulatory agencies in the Asia-Pacific region.
South-East Asian Region (SEAR): Bangladesh, India, Indonesia, Korea, Myanmar, Thailand
Western Pacific Region (WPR): Cambodia, Lao PDR, Singapore, Viet Nam
Malaria Elimination and Communicable Disease Control
Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Capacity Development of National Regulatory Authorities in the Greater Mekong Subregion to Facilitate the Elimination of Malaria
[Coming Soon] Ensuring Sustainable, Locally Relevant Vaccine Research and Development in Lower-Resourced Settings
[Coming Soon] ADB-CoRE Policy: Manufacturing and Other Considerations of Vaccines Technologies in Lower-Resourced Settings
[Coming Soon] ADB-CoRE Policy: Fit-for-Purpose, Confidence-Based Regulation across the Vaccine Life Cycle: A Path for Asia Pacific to Enhance Pandemic Preparedness
[Coming Soon] ADB-CoRE Policy Brief: Building Sustainable Vaccine Manufacturing Practices in Lower-Resourced Settings
More Publications Coming Soon
To enjoy the full experience, please upgrade your browser